Elanco Animal Health Incorporated (ELAN)
NYSE: ELAN · Real-Time Price · USD
22.12
-0.15 (-0.67%)
At close: Oct 28, 2025, 4:00 PM EDT
22.35
+0.23 (1.03%)
After-hours: Oct 28, 2025, 7:42 PM EDT
Elanco Animal Health Employees
As of December 31, 2024, Elanco Animal Health had 9,450 total employees, including 9,000 full-time and 450 part-time employees. The number of employees decreased by 350 or -3.57% compared to the previous year.
Employees
9,450
Change (1Y)
-350
Growth (1Y)
-3.57%
Revenue / Employee
$474,497
Profits / Employee
$45,926
Market Cap
10.99B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9,450 | -350 | -3.57% |
| Dec 31, 2023 | 9,800 | 60 | 0.62% |
| Dec 31, 2022 | 9,740 | 740 | 8.22% |
| Dec 31, 2021 | 9,000 | -1,200 | -11.76% |
| Dec 31, 2020 | 10,200 | 4,120 | 67.76% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ELAN News
- 1 day ago - Elanco Announces Expansion of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) and Credelio™ (lotilaner) Labels, Offering Protection Against Lyme Disease and an Emerging Tick Species - PRNewsWire
- 4 days ago - Elanco gets US FDA emergency nod for dog drug as threat of flesh-eating parasite looms - Reuters
- 4 days ago - Elanco Animal Health Obtains FDA Authorization for Screwworm Treatment - WSJ
- 4 days ago - Elanco's Credelio™ (lotilaner) Receives First Ever FDA Emergency Use Authorization (EUA) against New World Screwworm (NWS) in Dogs - PRNewsWire
- 12 days ago - Elanco to Host Investor Day on December 9 - PRNewsWire
- 27 days ago - Elanco Confirms Date and Conference Call for Third Quarter 2025 Financial Results Announcement - PRNewsWire
- 5 weeks ago - Elanco Announces FDA Approves Improved Zenrelia™ (ilunocitinib tablets) Label, Removing Vaccine-Induced Disease Language - PRNewsWire
- 7 weeks ago - Elanco Animal Health Incorporated (ELAN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) - Seeking Alpha